List view / Grid view
24 May 2016 | By Victoria White, Digital Content Producer
Prof. Dr. Axel Dignass said the data show that Adacolumn provided clinical benefit in steroid-dependent patients with UC with previous failure to biologics...
24 May 2016 | By Victoria White, Digital Content Producer
As part of the update, the black triangle symbol, indicating that additional safety monitoring for Champix in the UK was required, has been removed...
23 May 2016 | By Victoria White, Digital Content Producer
Daratumumab is the first CD38-directed mAb approved in Europe. It binds to CD38, a signalling molecule expressed on the surface of multiple myeloma cells...
23 May 2016 | By Victoria White, Digital Content Producer
Helperby is about to begin clinical studies of a completely new approach to fighting resistant bacteria following a positive meeting with the FDA...
23 May 2016 | By Victoria White, Digital Content Producer
Commenting on the launch, Maurizio Castorina, CEO of Zambon, said safinamide offers PD patients "a novel therapeutic option"...
23 May 2016 | By CPhI
UBM EMEA, leading organisers of CPhI Russia and CPhI South East Asia, provide an Asia trends update following the closing of its events...
20 May 2016 | By L.B. Bohle Maschinen + Verfahren GmbH,
Sales Office relocates from Goa to the metropolis of Mumbai...
20 May 2016 | By Katie Sadler
NICE has announced it will not be recommending pertuzumab to treat HER2-positive breast cancer because it is uncertain of the long term benefits for patients.
20 May 2016 | By Katie Sadler
Roche has announced that Alecensa, an oral anaplastic lymphoma kinase (ALK) inhibitor, reduced the risk of disease worsening or death in Japanese people with advanced or recurrent, ALK-positive non-small cell lung cancer (NSCLC).
19 May 2016 | By Katie Sadler
The European Association for the Study of Obesity (EASO) has issued a warning urging for action to tackle the regions rising obesity epidemic.
18 May 2016 | By Katie Sadler
New data has revealed tiotropium improves lung function in children who continue to experience asthma symptoms despite taking other maintenance therapies.
18 May 2016 | By Mandy Parrett, Editorial Assistant
Biopharmaceutical company, Newron, has announced that its Investigational New Drug (IND) application to evaluate Sarizotan in treatment of Rett Syndrome has been approved by the FDA.
17 May 2016 | By Katie Sadler
The European Medicines Agency (EMA) has accepted Bial’s submission for once-daily epilepsy treatment Zebinix as monotherapy for partial-onset seizures.
17 May 2016 | By RADWAG
Brand new adjustment system guarantees the highest measurement accuracy...
17 May 2016 | By The Black Swan Analysis
The Black Swan Analysis team are delighted to announce that their Senior Analyst, Christopher Bell, has been awarded the highly respected ‘Ian Burgess Award’ at the Annual British Healthcare Intelligence Association (BHBIA) conference in London...
